Candida Auris Cases: Drug-Resistant Fungus in 23 States

Candida auris is spreading faster than health officials can comfortably ignore. New Facilities for Illness Management and Prevention information present 3,130 confirmed Candida auris screening instances throughout 23 states as of July 18, in contrast with 3,348 screening instances on the identical level in 2025. These numbers sign that one of many world’s most harmful fungal pathogens is not slowing down.

Based on People, the most recent surge is being pushed nearly completely by healthcare settings, the place Candida auris spreads between weak sufferers via contaminated surfaces, shared medical tools, and shut contact. Texas has reported the nation’s highest screening depend, with 706 instances recorded via July 18, in contrast with 660 on the identical level in 2025.

COMPLEX SHOP: Shop the brands you love, anytime and anywhere. Uncover what’s next. Buy. Collect. Obsess.

In contrast to many infections, Candida auris hardly ever threatens wholesome folks. As a substitute, it targets sufferers who’re already critically sick, significantly these counting on respiratory tubes, IV traces, feeding tubes, or urinary catheters. The fungus will also be carried by folks with no signs in any respect, permitting it to quietly unfold via healthcare services earlier than it is detected.

As soon as it enters the bloodstream, nevertheless, it will probably quickly escalate into sepsis, organ failure, and different life-threatening problems.

Medical doctors say the largest problem is not simply stopping the fungus—it is treating it. “What makes Candida auris particularly regarding is its resistance profile,” Nathan Wiederhold, PharmD, director of the Fungus Testing Laboratory and professor at The College of Texas at San Antonio, mentioned to the outlet. “Many strains are proof against azoles, one in every of our main antifungal drug lessons, and a few are additionally proof against amphotericin B, which is commonly thought of a drug of final resort.”

He added that fungal infections “may be way more troublesome to diagnose and deal with, and we’re seeing growing unfold and resistance.”

The newest spike builds on years of warnings from infectious illness specialists. First recognized in Japan in 2009 and detected within the U.S. 4 years later, Candida auris has now been reported in additional than 50 international locations. Researchers have documented strains proof against a number of antifungal medication—and, in uncommon instances, each main class of antifungal treatment.

As a result of the fungus is commonly mistaken for different organisms throughout routine testing, sufferers can expertise delays in receiving the fitting therapy whereas outbreaks proceed to develop.

Though Candida auris stays largely confined to healthcare environments, its increasing footprint has made it one of many CDC’s most carefully watched rising threats. Earlier company estimates discovered that 30% to 60% of contaminated sufferers died, although many had severe underlying diseases that additionally contributed to these outcomes.